Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results HOLLISTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial…
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting Advanced platforms for CROs, pharmaceutical and biotech companies seeking to enhance productivity Advanced platforms for CROs, pharmaceutical and biotech companies…
Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference HOLLISTON, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green,…
Harvard Bioscience Aktie: Diese News macht Mut! Die Harvard Bioscience Aktie verzeichnete am letzten Handelstag eine positive Entwicklung mit einem Kursanstieg von 3,70 Prozent auf 2,24 USD.…
Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET HOLLISTON, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results…
Harvard Bioscience Announces Second Quarter 2024 Financial Results HOLLISTON, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial…
Earnings call: Harvard Bioscience faces Q1 challenges, eyes H2 recovery By Investing.com Earnings call: Harvard Bioscience faces Q1 challenges, eyes H2 recovery…
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET HOLLISTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results…
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth HOLLISTON, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced a labor force…
Harvard Bioscience shares get price target boost to $6.75 By Investing.com Harvard Bioscience shares get price target boost to $6.75…
Earnings call: Harvard Bioscience reports steady performance amid challenges By Investing.com Earnings call: Harvard Bioscience reports steady performance amid challenges…
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results HOLLISTON, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial…
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET HOLLISTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results…